Notable Labs Inc.
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically … Read more
Market Cap & Net Worth: Notable Labs Inc. (NTBL)
Notable Labs Inc. (NASDAQ:NTBL) has a market capitalization of $202.85K ($202.85K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #42568 globally and #13745 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Notable Labs Inc.'s stock price $0.02 by its total outstanding shares 9659500 (9.66 Million).
Notable Labs Inc. Market Cap History: 2015 to 2024
Notable Labs Inc.'s market capitalization history from 2015 to 2024. Data shows change from $1.78 Billion to $202.85K (-64.40% CAGR).
Notable Labs Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Notable Labs Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
58.89x
Notable Labs Inc.'s market cap is 58.89 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $405.70 Million | $562.00K | -$19.40 Million | 721.88x | N/A |
| 2020 | $638.98 Million | $922.00K | -$24.23 Million | 693.03x | N/A |
| 2021 | $666.02 Million | $285.00K | -$16.05 Million | 2336.92x | N/A |
| 2022 | $40.57 Million | $8.00K | -$14.41 Million | 5071.24x | N/A |
| 2023 | $18.26 Million | $310.00K | -$11.26 Million | 58.89x | N/A |
Competitor Companies of NTBL by Market Capitalization
Companies near Notable Labs Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Notable Labs Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Notable Labs Inc. Historical Marketcap From 2015 to 2024
Between 2015 and today, Notable Labs Inc.'s market cap moved from $1.78 Billion to $ 202.85K, with a yearly change of -64.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $202.85K | -98.89% |
| 2023 | $18.26 Million | -55.00% |
| 2022 | $40.57 Million | -93.91% |
| 2021 | $666.02 Million | +4.23% |
| 2020 | $638.98 Million | +57.50% |
| 2019 | $405.70 Million | +23.71% |
| 2018 | $327.94 Million | -86.34% |
| 2017 | $2.40 Billion | +46.39% |
| 2016 | $1.64 Billion | -7.79% |
| 2015 | $1.78 Billion | -- |
End of Day Market Cap According to Different Sources
On Dec 19th, 2025 the market cap of Notable Labs Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $202.85K USD |
| MoneyControl | $202.85K USD |
| MarketWatch | $202.85K USD |
| marketcap.company | $202.85K USD |
| Reuters | $202.85K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.